0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology

Buy Now

Targeted Drug Strategies for Cancer and Inflammation (Paperback, 2011 ed.) Loot Price: R4,221
Discovery Miles 42 210
Targeted Drug Strategies for Cancer and Inflammation (Paperback, 2011 ed.): Ann L. Jackman, Christopher P. Leamon

Targeted Drug Strategies for Cancer and Inflammation (Paperback, 2011 ed.)

Ann L. Jackman, Christopher P. Leamon

 (sign in to rate)
Loot Price R4,221 Discovery Miles 42 210 | Repayment Terms: R396 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Folate pathways are essential in metabolism and macromolecule synthesis. Antifolate drugs that are largely transported via a high capacity folate transporter (i.e. the reduced-folate carrier) and inhibit folate-dependent enzymes include the dihydrofolate reductase inhibitor, methotrexate, and the thymidylate synthase inhibitors, raltitrexed and pemetrexed. Major advances in folate research made within the last decade include (i) the approval of pemetrexed for the treatment of lung cancer and mesothelioma, and (ii) the demonstration that cell membrane-anchored folate receptors (FR) are exploitable for cancer and inflammatory disease management. FRs are not widely distributed in normal tissues, except on some luminal surfaces; however, they are accessible to systemically administered agents when expressed on many cancers as well as on activated macrophages involved in various inflammatory diseases. High affinity folate-radioisotope conjugates have been developed for imaging pathogenic FR-positive diseases, including cancer. Since the FR transports folates via a low capacity but high affinity endocytic pathway, a variety of FR-targeted antifolate drugs and folate conjugates bearing a wide range of payloads (including cytotoxic drugs) are currently being developed which exploit this property. The FR is also being utilized in immunotherapy approaches for the treatment of overexpressing cancers.

General

Imprint: Springer-Verlag New York
Country of origin: United States
Release date: October 2014
First published: 2011
Editors: Ann L. Jackman • Christopher P. Leamon
Dimensions: 235 x 155 x 14mm (L x W x T)
Format: Paperback
Pages: 254
Edition: 2011 ed.
ISBN-13: 978-1-4899-8886-7
Categories: Books > Medicine > Other branches of medicine > Pharmacology > General
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN: 1-4899-8886-6
Barcode: 9781489988867

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners